Skip to main content
. 2019 Mar 20;10:261. doi: 10.3389/fneur.2019.00261

Table 2.

Frequency of cognitive impairment (CI) in patients with CIS compared with matched HC or national normative data.

References CIS n HS n % CI CIS Definition CI NP battery DD
Feuillet et al. (16) 40*** 30 57 ≥2 tests ≤ 2SD BRB-N + other tests 2.89/0.5 (1–3) months
Potagas et al. (17) 33 43 27.3 >2 scores < 1.64 SD (5th percentile) BRB-N 1.0 (1.5) years
Zipoli et al. (18) 61 Normative data 25 ≥2 tests ≤ 2SD BRB-N + Stroop < 3 months
Khalil et al. (19) 44 Normative data 18.2 >1 test (z score < 1.64) (5th percentile) BRB-N 0.2 (0.1–0.8) years
Reuter et al. (20) 97*,** 55 20 ≥2 scores < 1.64 SD (5th percentile) BRB-N 5.0 (116, 21) months
Vitterbo et al. (22) 100 Normative data 21 ≥2 scores < 1.5 SD BRB-N < 12 months
Uher et al. (23) 81** 134 12.3 ≥2 scores < 1.5 SD MACFIMS < 4 months
Ruano et al. (10) 167 Normative data 34.5% ≥2 scores < 1.64 SD in ≥2 domains BRB-N 1.4 (2.2) years

CIS, clinically isolated syndromes; CI, cognitive impairment; NP, neuropsychological; DD, disease duration; BRB-N, Brief-Repeatable Battery of neuropsychological tests; MACFIMS, Minimal Assessment of Cognitive Function in Multiple Sclerosis. SD, standard deviation.

*

Oligoclonal bands in cerebrospinal fluid.

**

>1 lesion brain or cord magnetic resonance imaging.

***

Dissemination in space on magnetic resonance imaging.